Cancer diagnoses diminishes adherence to diabetes medications
the ONA take:
According to a new study published in the journal Diabetologia, patients with diabetes become less adherent to their antihyperglycemic medications after receiving a cancer diagnosis.
For the study, researchers sought to evaluate changes in adherence to antihyperglycemic medications used to treat diabetes after a diagnosis of cancer. Researchers identified 52,228 antihyperglycemic mediation users from the Eindhoven Cancer Registry-PHARMO Database Network in the Netherlands between 1998 and 2011. Of those, they identified 3,281 cases with cancer and 12,891 controls without cancer.
Results showed that before a cancer diagnosis, the medication possession ratio (MPR), an indicator for medication adherence, was increased by 0.10% per month. At the time of cancer diagnosis, researchers found that the MPR decreased by 6.3%, which continued to decline by 0.20% monthly thereafter.
Patients diagnosed with stage 4 cancer and those with gastroinestinal or pulmonary cancers had the largest declines in MPR. The initial 6% MPR decrease translates to a patient missing 2 days of their antihyperglycemic medications.
The findings suggest that a cancer diagnosis can diminish adherence to medications of patients' other chronic conditions.
Patients with diabetes become less adherent to their antihyperglycemic medications after receiving a cancer diagnosis.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Radiotherapy is Essential in Treating Brain Tumors But Associated With Significant Adverse Events
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|